EZH2 expression in invasive lobular carcinoma of the breast

BACKGROUND: Invasive lobular carcinoma (ILC) is the second most common histologic type of breast cancer, but the prognosis of ILC is still controversial. Enhancer of Zeste homolog 2 (EZH2), the catalytic subunit of the Polycomb repressive complex 2 (PRC2), is frequently overexpressed in various canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Roh, SiGyun, Park, Shin Young, Ko, Hyoung Suk, Sohn, Jang Sihn, Cha, Eun Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222266/
https://www.ncbi.nlm.nih.gov/pubmed/24266940
http://dx.doi.org/10.1186/1477-7819-11-299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222266/
https://www.ncbi.nlm.nih.gov/pubmed/24266940
http://dx.doi.org/10.1186/1477-7819-11-299

Ejemplares similares